RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,441,537 | +29.0% | 4,785,494 | 0.0% | 2.81% | +30.5% |
| Q2 2023 | $28,253,557 | -1.3% | 4,785,494 | 0.0% | 2.16% | +9.0% |
| Q1 2023 | $28,617,254 | +156.7% | 4,785,494 | 0.0% | 1.98% | +215.5% |
| Q4 2022 | $11,150,201 | -30.5% | 4,785,494 | -0.0% | 0.63% | -21.6% |
| Q3 2022 | $16,036,000 | +26.4% | 4,786,921 | 0.0% | 0.80% | +22.7% |
| Q2 2022 | $12,685,000 | -9.9% | 4,786,921 | 0.0% | 0.65% | +60.6% |
| Q1 2022 | $14,073,000 | -65.6% | 4,786,921 | 0.0% | 0.41% | -50.9% |
| Q4 2021 | $40,928,000 | +14.8% | 4,786,921 | 0.0% | 0.83% | +95.0% |
| Q3 2021 | $35,663,000 | -20.1% | 4,786,921 | 0.0% | 0.42% | -27.1% |
| Q2 2021 | $44,662,000 | – | 4,786,921 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,962,221 | $18,190,000 | 5.62% |
| RiverVest Venture Management LLC | 2,409,220 | $22,478,000 | 4.39% |
| Novo Holdings A/S | 3,430,377 | $32,005,000 | 1.42% |
| Aisling Capital Management LP | 886,075 | $8,267,000 | 1.32% |
| NEA Management Company, LLC | 4,786,921 | $44,662,000 | 0.58% |
| Prosight Management, LP | 54,934 | $513,000 | 0.32% |
| Rock Springs Capital Management LP | 1,129,024 | $10,534,000 | 0.21% |
| Pinz Capital Management, LP | 56,823 | $530,000 | 0.16% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 750,000 | $6,998,000 | 0.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 849,300 | $7,924,000 | 0.14% |